Vitamin D receptor activators.

Sandro Mazzaferro, Marzia Pasquali, Carmina Conte, Giusy Mandanici, Maria Muci, Raffaella Lavini

Journal: The International journal of artificial organs 2009;32(2):101-7

PMID: 19363782

Abstract

The fields for clinical employment of vitamin D analogs are growing and under active evaluation in different medical specialties, ranging from dermatology to immunology and oncology. In this review we provide a brief description of the drugs that have been developed more specifically for the treatment of secondary hyperparathyroidism (SH) associated with uremia.

Address: Department of Clinical Science, Sapienza University of Rome and Chair of Nephrology, Sapienza University of Rome, Rome - Italy. [email protected]

DOI: 10.1177/039139880903200207

Link outs

Free resources

Medical:

https://medlineplus.gov/vitamind.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Calcitriol, Dihydroxycholecalciferols, Ergocalciferols, Humans, Hyperparathyroidism, Secondary, Uremia, Vitamin D